What medication can be given to a 14-year-old using a mixed THC (tetrahydrocannabinol) and nicotine e-cigarette to achieve a similar effect that is appropriate for her?

No Medication Should Be Given to Replicate THC/Nicotine Effects in a 14-Year-Old

There is no appropriate medication that should be prescribed to a 14-year-old to replicate the psychoactive effects of THC and nicotine from vaping. This is fundamentally a substance use disorder requiring cessation treatment, not substitution therapy.

The Core Issue: Substance Dependence, Not Symptom Management

Your daughter is using addictive substances that are harmful to her developing brain. Both nicotine and THC act as neuroteratogens during adolescence, affecting brain structure and chemistry in ways that can impair cognitive development, memory formation, and emotional regulation 1. The goal must be complete cessation, not finding a "safer" alternative that provides similar euphoric effects.

Why Substitution Is Not the Answer

• No FDA-approved medications exist to provide THC-like psychoactive effects for any age group, let alone adolescents
• Nicotine is highly addictive in the adolescent brain, with receptors showing higher functional activity during ages 13-18 than in adulthood 1
• Seeking to replicate these effects medicalizes recreational drug use and reinforces substance-seeking behavior rather than addressing the underlying dependence

What Should Actually Be Done

1. Immediate Behavioral Intervention (First-Line Treatment)

Counseling and behavioral therapy are the primary evidence-based treatments for adolescent nicotine and cannabis dependence 2. This includes:

• Cognitive-behavioral therapy focusing on problem-solving skills and providing support 2, 3
• The "5 As" model: Ask about use, Advise to quit with personally relevant messages, Assess dependence severity and readiness to change, Assist with tailored support, Arrange follow-up 2
• Motivational interviewing aligned with her developmental stage 3

Messages that resonate with adolescents include effects on appearance, breath, sports performance, cost of continued addiction, and how the tobacco/cannabis industry deceives them 2.

2. Free Cessation Resources

• 1-800-QUIT-NOW: National quitline with proven effectiveness 2
• SmokefreeTXT: Text QUIT to 47848 for mobile-based support 2
• quitSTART app: Smartphone app designed specifically for teens 2

3. Pharmacotherapy (Only If Moderate-to-Severe Dependence)

Tobacco dependence pharmacotherapy can be considered for moderate to severely tobacco-dependent adolescents who want to stop smoking 2. However, critical caveats apply:

• No FDA approval exists for anyone under 18 years for any tobacco/nicotine dependence medication 2
• Medications require a prescription from a licensed provider even for over-the-counter products in adolescents 2
• This is off-label use requiring careful risk-benefit analysis 4, 5

Available options (if behavioral treatments are insufficient):

• Nicotine replacement therapy (patch, gum, lozenges): Long-acting patch as foundation, with short-acting forms for breakthrough cravings 2
• Bupropion (prescription): Requires monitoring for seizure risk and psychiatric symptoms 2, 4
• Varenicline (prescription): Black box warning for psychiatric side effects, though recent meta-analysis shows efficacy in young adults 2, 4, 6

Combination therapy is more effective than single medication for moderate-to-severe dependence 2.

4. Cannabis-Specific Considerations

For the THC component:

• No FDA-approved medications exist for cannabis use disorder in any age group
• Behavioral interventions remain the only evidence-based approach
• Interestingly, nicotine patch has shown some efficacy in reducing negative affect during cannabis withdrawal in adults, but this is not standard practice and not studied adequately in adolescents 7

5. Critical Monitoring Requirements

If pharmacotherapy is considered:

• Screen for psychiatric comorbidities (depression, anxiety, ADHD) which commonly accompany substance dependence and require separate treatment 2
• Monitor for suicidal ideation during both continued use and cessation attempts 2
• Assess seizure risk before bupropion or varenicline 4
• Regular follow-up to adjust treatment based on withdrawal symptoms and relapse risk 2

What NOT to Do

Do not recommend electronic nicotine delivery systems (e-cigarettes) for cessation - they are not FDA-approved, not proven safe or effective, and are associated with decreased cessation rates in adolescents 2.

Do not prescribe cannabinoids (nabilone, dronabinol) to replicate THC effects - these are approved only for chemotherapy-induced nausea and have significant cognitive impairment, dizziness, and dysphoria as side effects 8.

The Bottom Line

Your daughter needs substance use disorder treatment, not medication to replicate drug effects. Start with behavioral counseling through school resources or the national quitline. If she has moderate-to-severe dependence (daily use, failed quit attempts, withdrawal symptoms), consider referral to an addiction specialist who can evaluate for off-label pharmacotherapy under close supervision. The developing adolescent brain is uniquely vulnerable to these substances 1, making early intervention critical for her long-term cognitive and mental health.